Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Lumentum
LITE
$63.3B
| $3.67M | ﹤0.01% |
45,111
-6,793
| -13% | -$518K |
|
1602
Assembly Biosciences
ASMB
$530M
| $3.67M | ﹤0.01% |
13,110
+38
| +0.3% | +$8.87K |
|
1603
KB Home
KBH
$3.47B
| $3.67M | ﹤0.01% |
119,570
-189,469
| -61% | -$5.21M |
|
1604
PUT
Quest Diagnostics
DGX
$26.2B
| $3.66M | ﹤0.01% |
32,100
-9,100
| -22% | -$965K |
|
|
MNTA
1605
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.66M | ﹤0.01% |
109,934
+3,101
| +3% | +$98.7K |
|
1606
SSR Mining
SSRM
$6.4B
| $3.65M | ﹤0.01% |
171,336
+170,400
| +18,205% | +$3.06M |
|
1607
PUT
MGM Resorts International
MGM
$10.9B
| $3.65M | ﹤0.01% |
217,400
-1,178,300
| -84% | -$19M |
|
1608
Exelixis
EXEL
$13.1B
| $3.64M | ﹤0.01% |
153,277
-773,055
| -83% | -$17.9M |
|
|
NVRO
1609
DELISTED
NEVRO CORP.
NVRO
| $3.64M | ﹤0.01% |
30,426
+20,232
| +198% | +$2.4M |
|
1610
APA Corp
APA
$14.4B
| $3.61M | ﹤0.01% |
267,284
-747,390
| -74% | -$8.53M |
|
1611
Toronto Dominion Bank
TD
$200B
| $3.61M | ﹤0.01% |
80,848
+5,659
| +8% | +$241K |
|
1612
PUT
Bath & Body Works
BBWI
$3.89B
| $3.61M | ﹤0.01% |
297,993
-55,294
| -16% | -$616K |
|
1613
Helen of Troy
HELE
$680M
| $3.61M | ﹤0.01% |
19,129
+1,537
| +9% | +$252K |
|
1614
CALL
Nutanix
NTNX
$17.4B
| $3.6M | ﹤0.01% |
151,800
-126,400
| -45% | -$2.62M |
|
|
SEE
1615
DELISTED
Sealed Air
SEE
| $3.6M | ﹤0.01% |
109,588
-222,593
| -67% | -$6.68M |
|
|
KL
1616
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $3.6M | ﹤0.01% |
87,179
-58,208
| -40% | -$2.25M |
|
1617
PUT
Ares Capital
ARCC
$14.3B
| $3.59M | ﹤0.01% |
248,600
-540,900
| -69% | -$7.3M |
|
|
VCRA
1618
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $3.59M | ﹤0.01% |
169,462
-19,012
| -10% | -$373K |
|
1619
Yeti Holdings
YETI
$3.99B
| $3.58M | ﹤0.01% |
83,724
+41,655
| +99% | +$1.25M |
|
1620
Simply Good Foods
SMPL
$956M
| $3.58M | ﹤0.01% |
192,319
+28,001
| +17% | +$496K |
|
1621
Under Armour Class C
UA
$2.44B
| $3.57M | ﹤0.01% |
404,213
-256,192
| -39% | -$2.18M |
|
1622
Tenet Healthcare
THC
$20.9B
| $3.56M | ﹤0.01% |
196,813
+54,559
| +38% | +$1.07M |
|
1623
B2Gold
BTG
$6.68B
| $3.56M | ﹤0.01% |
625,665
+625,254
| +152,130% | +$3.13M |
|
1624
NeoGenomics
NEO
$2.14B
| $3.56M | ﹤0.01% |
114,826
+13,339
| +13% | +$370K |
|
|
1625
CALL
Quest Diagnostics
DGX
$26.2B
| $3.56M | ﹤0.01% |
31,200
-39,500
| -56% | -$4.19M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.